Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Radiation With Androgen Deprivation: Abiraterone Acetate, Prednisone and Luteinizing Hormone Releasing Hormone Agonist Prior to Radiation Therapy

NCT01023061 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01023061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01023061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Radiation With Androgen Deprivation: Abiraterone Acetate, Prednisone and Luteinizing Hormone Releasing Hormone Agonist Prior to Radiation Therapy
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
September 30, 2015
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, stage ii prostate cancer, stage iii prostate cancer, stage iv prostate cancer